We are live on ! Find out more
MTFB

Motif Bio plc ADRs
MTFB

Delisted

MTFB was delisted on the 16th of December, 2019.

3 hedge funds and large institutions have $10.4M invested in Motif Bio plc ADRs in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

12% less capital invested

Capital invested by funds: $11.8M → $10.4M (-$1.42M)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$12.6K
2
TRCT
Tower Research Capital (TRC)
New York
+$1.03K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$2K
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
1
Invesco
Georgia
$10.4M
UBS Group
2
UBS Group
Switzerland
$15K +$12.6K +1,227 +402%
TRCT
3
Tower Research Capital (TRC)
New York
$1K +$1.03K +100 New
Deutsche Bank
4
Deutsche Bank
Germany
-$2K -200 Closed

MTFB Hedge Fund Activity: Q1 2018 in Review

3 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q1 2018, worth a combined $10.4M — down 12% from $11.8M a quarter earlier.

Fund positioning in MTFB was balanced in Q1 2018: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $12.6K. The largest seller was Deutsche Bank, exiting entirely with an estimated $2K sold.

  • 3 institutional investors held Motif Bio plc ADRs (MTFB) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $10.4M of Motif Bio plc ADRs stock for Q1 2018, down 12% quarter-over-quarter.
  • 1 fund opened new Motif Bio plc ADRs positions in Q1 2018 and 1 closed out, a net change of 0 holders.
  • The largest Motif Bio plc ADRs buyer in Q1 2018 was UBS Group, an estimated $12.6K added.
  • The largest Motif Bio plc ADRs seller in Q1 2018 was Deutsche Bank, an estimated $2K sold.

Based on aggregated 13F filings for Q1 2018.